The role of natural polyphenols in cell signaling and cytoprotection against cancer development

Journal of Nutritional Biochemistry

Volumn 32, Issue , 2016, Pages 1-19

  Lewandowska, Hanna ^a   Kalinowska, Monika ^b   Lewandowski, Włodzimierz ^b   Stepkowski, Tomasz M ^a   Brzóska, Kamil ^a  

^a INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY   (Poland)

^b BIALYSTOK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Anticancer; Antioxidant; Caffeic acid; Chlorogenic acid; Phenolic compounds; Quercetin

Indexed keywords

ANTINEOPLASTIC AGENT; BECLIN 1; CAFFEIC ACID; CHLOROGENIC ACID; CURCUMIN; CYTOCHROME P450; CYTOPROTECTIVE AGENT; DRUG METABOLIZING ENZYME; HEAT SHOCK PROTEIN 72; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL; PROCYANIDIN B2; PROCYANIDIN DERIVATIVE; PROTEIN KINASE C DELTA; PROTEIN P62; QUERCETIN; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT; XENOBIOTIC METABOLIZING ENZYME; ANGIOGENESIS INHIBITOR; CINNAMIC ACID DERIVATIVE; FLAVONOID; SCAVENGER;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CANCER GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CPG ISLAND; DEACETYLATION; DIET; DNA DAMAGE; DNA METHYLATION; DNA REPLICATION; DOWN REGULATION; DRUG ABSORPTION; EPIGENETICS; GASTROINTESTINAL ABSORPTION; GENE MUTATION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; INTESTINE FLORA; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR DOCKING; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; TEA; XENOBIOTIC METABOLISM; ANIMAL; BIOLOGICAL MODEL; CARCINOGENESIS; DIET THERAPY; GENETIC EPIGENESIS; HEALTHY DIET; METABOLISM; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; AUTOPHAGY; CARCINOGENESIS; CINNAMATES; EPIGENESIS, GENETIC; FLAVONOIDS; FREE RADICAL SCAVENGERS; HEALTHY DIET; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLYPHENOLS; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION;

EID: 84961132405     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.11.006     Document Type: Review

References (261)

1. Ferrazzano G.F., Amato I., Ingenito A., Zarrelli A., Pinto G., Pollio A. Plant polyphenols and their anti-cariogenic properties: a review. Molecules 2011, 16:1486-1507.
2. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
3. Kuhnau J. Flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976, 24:117-191.
4. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073S-2085S.
5. Kalinowska M., Bielawska A., Lewandowska-Siwkiewicz H., Priebe W., Lewandowski W. Apples: content of phenolic compounds vs. variety, part of apple and cultivation model, extraction of phenolic compounds, biological properties. Plant Physiol Biochem 2014, 84:169-188.
6. Kondratyuk T.P., Pezzuto J.M. Natural product polyphenols of relevance to human health. Pharm Biol 2004, 42:46-63.
7. Vitaglione P., Napolitano A., Fogliano V. Cereal dietary fibre: a natural functional ingredient to deliver phenolic compounds into the gut. Trends Food Sci Technol 2008, 19:451-463.
8. Fogliano V., Corollaro M.L., Vitaglione P., Napolitano A., Ferracane R., Travaglia F., et al. In vitro bioaccessibility and gut biotransformation of polyphenols present in the water-insoluble cocoa fraction. Mol Nutr Food Res 2011, 55:S44-S55.
9. Marín L., Miguélez E.M., Villar C.J., Lombó F. Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. BioMed Res IntBioMed Res Int 2015, 2015. [18 pages].
10. Jaganath I.B., Crozier A. Dietary flavonoids and phenolic compounds. Plant Phenolics Hum 2009, 1-49. Health, John Wiley & Sons, Inc.
11. Day A.J., Cañada F.J., Díaz J.C., Kroon P.A., Mclauchlan R., Faulds C.B., et al. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 2000, 468:166-170.
12. Gee J.M., DuPont M.S., Day A.J., Plumb G.W., Williamson G., Johnson I.T. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr 2000, 130:2765-2771.
13. Bang S.H., Shim J., Kim D.H. Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing α-l-rhamnosidase from Bifidobacterium dentium. J Microbiol Biotechnol 2015, 25:18-25.
14. Nakagawa K., Okuda S., Miyazawa T. Dose-dependent incorporation of tea catechins,(-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 1997, 61:1981-1985.
15. Borges G., Lean M.E., Roberts S.A., Crozier A. Bioavailability of dietary (poly) phenols: a study with ileostomists to discriminate between absorption in small and large intestine. Food Funct 2013, 4:754-762.
16. Erk T., Hauser J., Williamson G., Renouf M., Steiling H., Dionisi F., et al. Structure-and dose-absorption relationships of coffee polyphenols. Biofactors 2014, 40:103-112.
17. Déprez S., Brezillon C., Rabot S., Philippe C., Mila I., Lapierre C., et al. Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J Nutr 2000, 130:2733-2738.
18. Day A.J., DuPont M.S., Ridley S., Rhodes M., Rhodes M.J., Morgan M.R., et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett 1998, 436:71-75.
19. Németh K., Plumb G.W., Berrin J.-G., Juge N., Jacob R., Naim H.Y., et al. Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 2003, 42:29-42.
20. Thilakarathna S.H., Rupasinghe H.P. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 2013, 5:3367-3387.
21. Donovan J.L., Crespy V., Manach C., Morand C., Besson C., Scalbert A., et al. Catechin is metabolized by both the small intestine and liver of rats. J Nutr 2001, 131:1753-1757.
22. Petri N., Tannergren C., Holst B., Mellon F.A., Bao Y., Plumb G.W., et al. Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Dispos 2003, 31:805-813.
23. O'Leary K.A., Day A.J., Needs P.W., Mellon F.A., O'Brien N.M., Williamson G. Metabolism of quercetin-7-and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003, 65:479-491.
24. Bell J.R., Donovan J.L., Wong R., Waterhouse A.L., German J.B., Walzem R.L., et al. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr 2000, 71:103-108.
25. Manach C., Morand C., Crespy V., Demigné C., Texier O., Régérat F., et al. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 1998, 426:331-336.
26. Crespy V., Aprikian O., Morand C., Besson C., Manach C., Demigné C., et al. Bioavailability of phloretin and phloridzin in rats. J Nutr 2001, 131:3227-3230.
27. Das N. Studies on flavonoid metabolism: absorption and metabolism of (+)-catechin in man. Biochem Pharmacol 1971, 20:3435-3445.
28. Kunnumakkara A.B., Anand P., Harikumar K.B., Aggarwal B.B. DNA damage and cancer chemoprevention by polyphenols. Chemoprevention Cancer DNA Damage Diet Factors 2009, 455-482. Wiley-VCH Verlag GmbH & Co. KGaA.
29. Zhu M., David Phillipson J., Greengrass P.M., Bowery N.E., Cai Y. Plant polyphenols: biologically active compounds or non-selective binders to protein?. Phytochemistry 1997, 44:441-447.
30. Yang C.S., Wang X., Lu G., Picinich S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009, 9:429-439.
31. Sang S., Hou Z., Lambert J.D., Yang C.S. Redox properties of tea polyphenols and related biological activities. Antioxid Redox Signal 2005, 7:1704-1714.
32. Schroeter H., Heiss C., Balzer J., Kleinbongard P., Keen C.L., Hollenberg N.K., et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 2006, 103:1024-1029.
33. Roberts L.J., Oates J.A., Linton M.F., Fazio S., Meador B.P., Gross M.D., et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 2007, 43:1388-1393.
34. Samiec P.S., Drews-Botsch C., Flagg E.W., Kurtz J.C., Sternberg P., Reed R.L., et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998, 24:699-704.
35. Björnstedt M., Xue J., Huang W., Akesson B., Holmgren A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem 1994, 269:29382-29384.
36. Michelet F., Gueguen R., Leroy P., Wellman M., Nicolas A., Siest G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem 1995, 41:1509-1517.
37. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
38. VanderJagt D.J., Garry P.J., Bhagavan H.N. Ascorbic acid intake and plasma levels in healthy elderly people. Am J Clin Nutr 1987, 46:290-294.
39. de Boer V.C., Dihal A.A., van der Woude H., Arts I.C., Wolffram S., Alink G.M., et al. Tissue distribution of quercetin in rats and pigs. J Nutr 2005, 135:1718-1725.
40. Wätjen W., Michels G., Steffan B., Niering P., Chovolou Y., Kampkötter A., et al. Low concentrations of flavonoids are protective in rat H4IIe cells whereas high concentrations cause DNA damage and apoptosis. J Nutr 2005, 135:525-531.
41. Vaidyanathan J.B., Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 2003, 307:745-752.
42. Spencer J.P., Abd El Mohsen M.M., Rice-Evans C. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Oxyg Club Calif Tribute Bruce N Ames 2004, 423:148-161.
43. Campos A., Duran N., Lopez-Alarcón C., Lissi E. Kinetic and stoichiometric evaluation of free radicals scavengers activities based on diphenyl-picryl hydrazyyl (dpph) consumption. J Chil Chem Soc 2012, 57:1381-1384.
44. Martínez A., Galano A., Vargas R. Free radical scavenger properties of α-mangostin: thermodynamics and kinetics of HAT and RAF mechanisms. J Phys Chem B 2011, 115:12591-12598.
45. Galano A., Francisco-Márquez M., Alvarez-Idaboy J.R. Canolol: a promising chemical agent against oxidative stress. J Phys Chem B 2011, 115:8590-8596.
46. Johnson P.S., Cook P.L., Liu X., Yang W., Bai Y., Abbott N.L., et al. Imide photodissociation investigated by X-ray absorption spectroscopy. J Phys Chem B 2012, 116:7048-7054.
47. Galano A., Martínez A. Capsaicin, a tasty free radical scavenger: mechanism of action and kinetics. J Phys Chem B 2012, 116:1200-1208.
48. Galano A., Alvarez-Idaboy J.R., Francisco-Márquez M. Physicochemical insights on the free radical scavenging activity of sesamol: importance of the acid/base equilibrium. J Phys Chem B 2011, 115:13101-13109.
49. Galano A., Francisco-Marquez M. Reactions of OOH radical with β-carotene, lycopene, and torulene: hydrogen atom transfer and adduct formation mechanisms. J Phys Chem B 2009, 113:11338-11345.
50. Galano A., Alvarez-Idaboy J.R. Glutathione: mechanism and kinetics of its non-enzymatic defense action against free radicals. RSC Adv 2011, 1:1763-1771.
51. Stalmach A., Troufflard S., Serafini M., Crozier A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res 2009, 53:S44-S53.
52. Isin E.M., Guengerich F.P. Complex reactions catalyzed by cytochrome P450 enzymes. BBA Gen Subj 1770, 2007:314-329.
53. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F.P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994, 270:414-423.
54. Doostdar H., Burke M.D., Mayer R.T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000, 144:31-38.
55. Henderson M., Miranda C., Stevens J., Deinzer M., Buhler D. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 2000, 30:235-251.
56. Pang C.Y., Mak J.W., Ismail R., Ong C.E. In vitro modulatory effects of flavonoids on human cytochrome P450 2C8 (CYP2C8). Naunyn Schmiedebergs Arch Pharmacol 2012, 385:495-502.
57. Tsyrlov I.B., Mikhailenko V.M., Gelboin H.V. Isozyme-and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. BBA-Protein Struct M 1994, 1205:325-335.
58. Zahn J.A., Arciero D.M., Hooper A.B., DiSpirito A.A. Evidence for an iron center in the ammonia monooxygenase from Nitrosomonas europaea. FEBS Lett 1996, 397:35-38.
59. Hodek P., Trefil P., Stiborová M. Flavonoids - potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2002, 139:1-21.
60. Chen Z., Zheng S., Li L., Jiang H. Metabolism of flavonoids in human: a comprehensive review. Curr Drug Metab 2014, 15:48-61.
61. Gradolatto A., Canivenc-Lavier M.-C., Basly J.-P., Siess M.-H., Teyssier C. Metabolism of apigenin by rat liver phase I and phase Ii enzymes and by isolated perfused rat liver. Drug Metab Dispos 2004, 32:58-65.
62. Stepkowski T.M., Kruszewski M.K. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. Free Radic Biol Med 2011, 50:1186-1195.
63. Zhang Q., Pi J., Woods C.G., Andersen M.E. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol 2010, 244:84-97.
64. Baird L., Llères D., Swift S., Dinkova-Kostova A.T. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci 2013, 110:15259-15264.
65. Na H.-K., Surh Y.-J. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol 2008, 46:1271-1278.
66. Na H.-K., Kim E.-H., Jung J.-H., Lee H.-H., Hyun J.-W., Surh Y.-J. (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys 2008, 476:171-177.
67. Farombi E.O., Shrotriya S., Na H.-K., Kim S.-H., Surh Y.-J. Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 2008, 46:1279-1287.
68. Soetikno V., Sari F.R., Lakshmanan A.P., Arumugam S., Harima M., Suzuki K., et al. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol Nutr Food Res 2012, 57:1649-1659.
69. Balstad T.R., Carlsen H., Myhrstad M.C., Kolberg M., Reiersen H., Gilen L., et al. Coffee, broccoli and spices are strong inducers of electrophile response element-dependent transcription in vitro and in vivo - studies in electrophile response element transgenic mice. Mol Nutr Food Res 2011, 55:185-197.
70. Liu S., Hou W., Yao P., Li N., Zhang B., Hao L., et al. Heme oxygenase-1 mediates the protective role of quercetin against ethanol-induced rat hepatocytes oxidative damage. Toxicol In Vitro 2012, 26:74-80.
71. Tanigawa S., Fujii M., Hou D.-X. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med 2007, 42:1690-1703.
72. Feng R., Lu Y., Bowman L.L., Qian Y., Castranova V., Ding M. Inhibition of activator protein-1, NF-κB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 2005, 280:27888-27895.
73. Illingworth R.S., Bird A.P. CpG islands - "a rough guide". Prague Spec Issue Funct Genomics Proteomics 2009, 583:1713-1720.
74. Stepanić V., Kujundžić R.N., Trošelj K.G. Epigenome, Cancer Prevention and Flavonoids and Curcumin 2014.
75. Granado-Serrano A.B., Martín M., Bravo L., Goya L., Ramos S. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact 2012, 195:154-164.
76. Mukai R., Ashida H., Terao J., Saito N., Shirai Y. Determination of Subcellular Localization of Flavonol in Cultured Cells by Laser Scanning 2011, INTECH Open Access Publisher.
77. Sharma H., Gupta S. Sub-cellular distribution and antioxidant potential of plant flavonoid apigenin. Cancer Res 2011, 71:4632-4632.
78. Kunwar A., Barik A., Mishra B., Rathinasamy K., Pandey R., Priyadarsini K. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. BBA Gen Subj 1780, 2008:673-679.
79. Han D.-W., Matsumura K., Kim B., Hyon S.-H. Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells. Bioorg Med Chem 2008, 16:9652-9659.
80. Patra S., Rizzi F., Silva A., Rugina D., Bettuzzi S. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J Physiol Pharmacol 2008, 59:217-235.
81. Gu L., Laly M., Chang H.C., Prior R.L., Fang N., Ronis M.J., et al. Isoflavone conjugates are underestimated in tissues using enzymatic hydrolysis. J Agric Food Chem 2005, 53:6858-6863.
82. Hendrich A.B. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds1. Acta Pharmacol Sin 2006, 27:27-40.
83. Thakur V.S., Gupta K., Gupta S. The chemopreventive and chemotherapeutic potentials of tea polyphenols. Curr Pharm Biotechnol 2012, 13:191-199.
84. Reuter S., Gupta S.C., Park B., Goel A., Aggarwal B.B. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 2011, 6:93-108.
85. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
86. Spange S., Wagner T., Heinzel T., Krämer O.H. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 2009, 41:185-198.
87. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 1998, 12:599-606.
88. Calvanese V., Lara E., Kahn A., Fraga M.F. The role of epigenetics in aging and age-related diseases. Ageing Res Rev 2009, 8:268-276.
89. Peserico A., Simone C. Physical and functional HAT/HDAC interplay regulates protein acetylation balance. BioMed Res Int 2010, 2011. [10 pages].
90. Dokmanovic M., Clarke C., Marks P.A. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 2007, 5:981-989.
91. Marks P.A., Richon V.M., Rifkind R.A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. JNCI J Natl Cancer Inst 2000, 92:1210-1216.
92. Thiagalingam S., Cheng K.-H., Lee H.J., Mineva N., Thiagalingam A., Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 2003, 983:84-100.
93. Thakur V.S., Gupta K., Gupta S. Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases. Int J Oncol 2012, 41:353-361.
94. Waldecker M., Kautenburger T., Daumann H., Busch C., Schrenk D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 2008, 19:587-593.
95. Choi K., Park S., Lim B., Sung A., Lee Y., Shiota M., et al. Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor. Biochem J 2011, 433:235-244.
96. Marcu M.G., Jung Y.-J., Lee S., Chung E.-J., Lee M.-J., Trepel J., et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2006, 2:169-174.
97. Choi K.-C., Jung M.G., Lee Y.-H., Yoon J.C., Kwon S.H., Kang H.-B., et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 2009, 69:583-592.
98. Lee Y.-H., Kwak J., Choi H.-K., Choi K.-C., Kim S., Lee J., et al. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. Int J Mol Med 2012, 30:69-74.
99. Sung B., Pandey M.K., Ahn K.S., Yi T., Chaturvedi M.M., Liu M., et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis. Blood 2008, 111:4880-4891.
100. Faus H., Haendler B. Androgen receptor acetylation sites differentially regulate gene control. J Cell Biochem 2008, 104:511-524.
101. Gong J., Zhu J., Goodman O., Pestell R., Schlegel P., Nanus D., et al. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene 2006, 25:2011-2021.
102. Fu M., Rao M., Wang C., Sakamaki T., Wang J., Di Vizio D., et al. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 2003, 23:8563-8575.
103. Xiao X., Shi D., Liu L., Wang J., Xie X., Kang T., et al. Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One 2011, 6:e22934.
104. Mutoh M., Takahashi M., Fukuda K., Matsushima-Hibiya Y., Mutoh H., Sugimura T., et al. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 2000, 21:959-963.
105. Balasubramanyam K., Varier R.A., Altaf M., Swaminathan V., Siddappa N.B., Ranga U., et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004, 279:51163-51171.
106. Kang J., Chen J., Shi Y., Jia J., Zhang Y. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 2005, 69:1205-1213.
107. Fu S., Kurzrock R. Development of curcumin as an epigenetic agent. Cancer 2010, 116:4670-4676.
108. Teiten M., Dicato M., Diederich M. Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 2013, 57:1619-1629.
109. Du L., Xie Z., Wu L., Chiu M., Lin J., Chan K.K., et al. Reactivation of RASSF1A in breast cancer cells by curcumin. Nutr Cancer 2012, 64:1228-1235.
110. Liu Z., Xie Z., Jones W., Pavlovicz R.E., Liu S., Yu J., et al. Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 2009, 19:706-709.
111. Chen S., Feng B., George B., Chakrabarti R., Chen M., Chakrabarti S. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab 2010, 298:E127-E137.
112. Chiu J., Khan Z.A., Farhangkhoee H., Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-κB. Nutrition 2009, 25:964-972.
113. Kang S.-K., Cha S.-H., Jeon H.-G. Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev 2006, 15:165-174.
114. Morimoto T., Sunagawa Y., Kawamura T., Takaya T., Wada H., Nagasawa A., et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008, 118:868-878.
115. Chen Y., Shu W., Chen W., Wu Q., Liu H., Cui G. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol 2007, 101:427-433.
116. Cui L., Miao J., Cui L. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother 2007, 51:488-494.
117. Barnes P.J. Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 2009, 71:451-464.
118. Meja K.K., Rajendrasozhan S., Adenuga D., Biswas S.K., Sundar I.K., Spooner G., et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol 2008, 39:312-323.
119. Bora-Tatar G., Dayangaç-Erden D., Demir A.S., Dalkara S., Yelekçi K., Erdem-Yurter H. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: activity and docking studies. Bioorg Med Chem 2009, 17:5219-5228.
120. Lee S.J., Krauthauser C., Maduskuie V., Fawcett P.T., Olson J.M., Rajasekaran S.A. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer 2011, 11:144-157.
121. Liu H., Chen Y., Cui G., Zhou J. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol Sin 2005, 26:603-609.
122. Shu L., Khor T.O., Lee J.-H., Boyanapalli S.S., Huang Y., Wu T.-Y., et al. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 2011, 13:606-614.
123. Chen C., Yu K., Yan Q., Xing C., Chen Y., Yan Z., et al. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class Ι histone deacetylases. Carcinogenesis 2013, 1442-1449.
124. Chan S.-T., Yang N.-C., Huang C.-S., Liao J.-W., Yeh S.-L. Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. PLoS One 2013, 8:e54255. [10 pages].
125. Jia J., Chen J. Histone hyperacetylation is involved in the quercetin-induced human leukemia cell death. Pharm Int J Pharm Sci 2008, 63:379-383.
126. Lee W.-J., Chen Y.-R., Tseng T.-H. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep 2011, 25:583-591.
127. Pandey M., Shukla S., Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int J Cancer 2010, 126:2520-2533.
128. Nandakumar V., Vaid M., Katiyar S.K. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011, 32:537-544.
129. Kim S.O., Kim M.R. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC-1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int J Oncol 2013, 42:349-358.
130. Mirza S., Sharma G., Parshad R., Gupta S.D., Pandya P., Ralhan R. Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer 2013, 16:23-31.
131. Basak S., Pookot D., Noonan E.J., Dahiya R. Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function. Mol Cancer Ther 2008, 7:3195-3202.
132. Groh I.A.M., Chen C., Lüske C., Cartus A.T., Esselen M. Plant polyphenols and oxidative metabolites of the herbal alkenylbenzene methyleugenol suppress histone deacetylase activity in human colon carcinoma cells. J Nutr Metab 2013, 2013. [10 pages].
133. Fang M.Z., Chen D., Sun Y., Jin Z., Christman J.K., Yang C.S. Reversal of hypermethylation and reactivation of p16INK4a, RARβ, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 2005, 11:7033-7041.
134. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 2008, 123:552-560.
135. Pandey M., Kaur P., Shukla S., Abbas A., Fu P., Gupta S. Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Mol Carcinog 2012, 51:952-962.
136. Berger A., Venturelli S., Kallnischkies M., Böcker A., Busch C., Weiland T., et al. Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. J Nutr Biochem 2013, 24:977-985.
137. de Boer V.C., de Goffau M.C., Arts I.C., Hollman P.C., Keijer J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev 2006, 127:618-627.
138. Singh N., Ravichandran S., Norton D.D., Fugmann S.D., Moaddel R. Synthesis and characterization of a SIRT6 open tubular column: predicting deacetylation activity using frontal chromatography. Anal Biochem 2013, 436:78-83.
139. Hong K.-S., Park J.-I., Kim M.-J., Kim H.-B., Lee J.-W., Dao T.T., et al. Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols. Toxicol Appl Pharmacol 2012, 259:210-218.
140. Fang M., Chen D., Yang C.S. Dietary polyphenols may affect DNA methylation. J Nutr 2007, 137:223S-228S.
141. Lee W.J., Shim J.-Y., Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 2005, 68:1018-1030.
142. Schramm L. Going green: the role of the green tea component EGCG in chemoprevention. J Carcinog Mutagen 2013, 4:1000142. [14 pages].
143. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003, 63:7563-7570.
144. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011, 82:1807-1821.
145. Rudolph T., Beuch S., Reuter G. Lysine-specific histone demethylase LSD1 and the dynamic control of chromatin. Biol Chem 2013, 394:1019-1028.
146. Chen Y., Jie W., Yan W., Zhou K., Xiao Y. Lysine-specific histone demethylase 1 (LSD1): a potential molecular target for tumor therapy. Crit Rev Eukaryot Gene Expr 2012, 22:53-59.
147. Abdulla A., Zhao X., Yang F. Natural polyphenols inhibit lysine-specific demethylase-1 in vitro. J Biochem Pharmacol Res 2013, 1:56-63.
148. Wilson A.S., Power B.E., Molloy P.L. DNA hypomethylation and human diseases. BBA-Rev Cancer 1775, 2007:138-162.
149. Link A., Balaguer F., Shen Y., Lozano J.J., Leung H.-C.E., Boland C.R., et al. Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One 2013, 8:e57709. [13 pages].
150. Jha A., Nikbakht M., Parashar G., Shrivastava A., Capalash N., Kaur J. Reversal of hypermethylation and reactivation of the RARbeta2 gene by natural compounds in cervical cancer cell lines. Folia Biol Praha 2010, 56:195-200.
151. Yoo J., Medina-Franco J.L., Yoo J., Medina-Franco J.L. Discovery and Optimization of Inhibitors of DNA Methyltransferase as Novel Drugs for Cancer Therapy 2011, INTECH Open Access Publisher.
152. Fang J.Y., Richardson B.C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005, 6:322-327.
153. Kyriakis J.M., Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012, 92:689-737.
154. Sebolt-Leopold J.S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 2000, 19:6594-6599.
155. Xavier C.P., Lima C.F., Preto A., Seruca R., Fernandes-Ferreira M., Pereira-Wilson C. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Lett 2009, 281:162-170.
156. Huang X., Chen S., Xu L., Liu Y., Deb D.K., Platanias L.C., et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 2005, 65:3470-3478.
157. Chen Y.-R., Tan T.-H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 1998, 17:173-178.
158. Prasad S., Ravindran J., Aggarwal B.B. NF-κB and cancer: how intimate is this relationship. Mol Cell Biochem 2010, 336:25-37.
159. Mackenzie G.G., Oteiza P.I. Modulation of transcription factor NF-κB in Hodgkin's lymphoma cell lines: effect of (-)-epicatechin. Free Radic Res 2006, 40:1086-1094.
160. Mackenzie G.G., Carrasquedo F., Delfino J.M., Keen C.L., Fraga C.G., Oteiza P.I. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-κB activation at multiple steps in Jurkat T cells. FASEB J 2004, 18:167-169.
161. Granado-Serrano A.B., Martín M.Á., Bravo L., Goya L., Ramos S. Quercetin attenuates TNF-induced inflammation in hepatic cells by inhibiting the NF-κB pathway. Nutr Cancer 2012, 64:588-598.
162. Yamaguchi M., Weitzmann M.N. Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts. Int J Mol Med 2011, 28:521-525.
163. Estrov Z., Shishodia S., Faderl S., Harris D., Van Q., Kantarjian H.M., et al. Resveratrol blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003, 102:987-995.
164. Divya C.S., Pillai M.R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 2006, 45:320-332.
165. Wahyudi S., Sargowo D. Green tea polyphenols inhibit oxidized LDL-induced NF-KB activation in human umbilical vein endothelial cells. Acta Med Indones 2007, 39:66-70.
166. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009, 1:a001651. [External Resource CrossRef DOI ISI Web Science n.d].
167. Dannenberg A.J., Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 2003, 4:431-436.
168. Peng G., Dixon D.A., Muga S.J., Smith T.J., Wargovich M.J. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 2006, 45:309-319.
169. Ye F., Wu J., Dunn T., Yi J., Tong X., Zhang D. Inhibition of cyclooxygenase-2 activity in head and neck cancer cells by genistein. Cancer Lett 2004, 211:39-46.
170. Grivennikov S.I., Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 2010, 20:65-71.
171. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
172. Kunnumakkara A.B., Anand P., Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008, 269:199-225.
173. Bode A.M., Ma W.-Y., Surh Y.-J., Dong Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 2001, 61:850-853.
174. Dampier K., Hudson E., Howells L., Manson M., Walker R., Gescher A. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer 2001, 85:618. [10 pages].
175. Majid S., Saini S., Dahiya R. Wnt signaling pathways in urological cancers: past decades and still growing. Mol Cancer 2012, 11:7. [13 pages].
176. Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3:768-780.
177. Jaiswal A.S., Marlow B.P., Gupta N., Narayan S. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 2002, 21:8414-8427.
178. Li Y., Wang Z., Kong D., Li R., Sarkar S.H., Sarkar F.H. Regulation of Akt/FOXO3a/GSK-3β/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 2008, 283:27707-27716.
179. Hope C., Planutis K., Planutiene M., Moyer M.P., Johal K.S., Woo J., et al. Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res 2008, 52:S52-S61.
180. Ahmad N., Cheng P., Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 2000, 275:328-334.
181. Park H.-K., Han D.-W., Park Y.H., Park J.-C. Differential biological responses of green tea polyphenol in normal cells vs. cancer cells. Curr Appl Phys 2005, 5:449-452.
182. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008, 52:507-526.
183. Hail N., Lotan R. Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state. Mol Nutr Food Res 2009, 53:49-67.
184. Strick R., Strissel P.L., Borgers S., Smith S.L., Rowley J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci 2000, 97:4790-4795.
185. Yokoyama M., Noguchi M., Nakao Y., Pater A., Iwasaka T. The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol Oncol 2004, 92:197-204.
186. Mehndiratta S., Kumar S., Meena A.K., Koul S., Suri O., Dhar K.L. A review on plants: a useful source of anti-cancer drugs. J Pharm Res 2011, 4:264-271.
187. Srivastava V., Negi A.S., Kumar J., Gupta M., Khanuja S.P. Plant-based anticancer molecules: a chemical and biological profile of some important leads. Bioorg Med Chem 2005, 13:5892-5908.
188. Bonfili L., Cecarini V., Amici M., Cuccioloni M., Angeletti M., Keller J.N., et al. Natural polyphenols as proteasome modulators and their role as anti-cancer compounds. FEBS J 2008, 275:5512-5526.
189. Filomeni G., De Zio D., Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ 2015, 22:377-388.
190. Hasima N., Ozpolat B. Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death Dis 2014, 5:e1509. [13 pages].
191. Song K.-S., Kim J.-S., Yun E.-J., Kim Y.-R., Seo K.-S., Park J.-H., et al. Rottlerin induces autophagy and apoptotic cell death through a PKC-delta-independent pathway in HT1080 human fibrosarcoma cells: the protective role of autophagy in apoptosis. Autophagy 2008, 4:650-658.
192. Lawrence C.P., Chow S.C. Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition properties. Toxicol Appl Pharmacol 2012, 265:103-112.
193. Zhi X., Zhong Q. Autophagy in cancer. F1000Prime Rep 2015, 7:18.
194. Funderburk S.F., Wang Q.J., Yue Z. The Beclin 1-VPS34 complex - at the crossroads of autophagy and beyond. Trends Cell Biol 2010, 20:355-362.
195. Nishida Y., Arakawa S., Fujitani K., Yamaguchi H., Mizuta T., Kanaseki T., et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 2009, 461:654-658.
196. Scarlatti F., Maffei R., Beau I., Codogno P., Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008, 15:1318-1329.
197. Zhu J., Horbinski C., Guo F., Watkins S., Uchiyama Y., Chu C.T. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am J Pathol 2007, 170:75-86.
198. Sharma K., Le N., Alotaibi M., Gewirtz D. Cytotoxic autophagy in cancer therapy. Int J Mol Sci 2014, 15:10034-10051.
199. Fruman D.A., Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 2014, 13:140-156.
200. Vanhaesebroeck B., Stephens L., Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol 2012, 13:195-203.
201. Gossner G., Choi M., Tan L., Fogoros S., Griffith K.A., Kuenker M., et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol 2007, 105:23-30.
202. Wang K., Liu R., Li J., Mao J., Lei Y., Wu J., et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy 2011, 7:966-978.
203. Shinojima N., Yokoyama T., Kondo Y., Kondo S. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 2007, 3:635-637.
204. Zhuang W., Long L., Zheng B., Ji W., Yang N., Zhang Q., et al. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci 2012, 103:684-690.
205. Han J., Pan X.-Y., Xu Y., Xiao Y., An Y., Tie L., et al. Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy 2012, 8:812-825.
206. Chadalapaka G., Jutooru I., Burghardt R., Safe S. Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Mol Cancer Res 2010, 8:739-750.
207. Trincheri N.F., Follo C., Nicotra G., Peracchio C., Castino R., Isidoro C. Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis 2008, 29:381-389.
208. Back J.H., Zhu Y., Calabro A., Queenan C., Kim A.S., Arbesman J., et al. Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis. Photochem Photobiol 2012, 88:1165-1172.
209. Balgi A.D., Fonseca B.D., Donohue E., Tsang T.C., Lajoie P., Proud C.G., et al. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 2009, 4:e7124. [15 pages].
210. Kueck A., Opipari A.W., Griffith K.A., Tan L., Choi M., Huang J., et al. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 2007, 107:450-457.
211. Klappan A., Hones S., Mylonas I., Brüning A. Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity. Histochem Cell Biol 2012, 137:25-36.
212. Armour S.M., Baur J.A., Hsieh S.N., Land-Bracha A., Thomas S.M., Sinclair D.A. Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging 2009, 1:515-528.
213. Psahoulia F.H., Moumtzi S., Roberts M.L., Sasazuki T., Shirasawa S., Pintzas A. Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells. Carcinogenesis 2007, 28:1021-1031.
214. Suchankova G., Nelson L.E., Gerhart-Hines Z., Kelly M., Gauthier M.-S., Saha A.K., et al. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 2009, 378:836-841.
215. Borra M.T., Smith B.C., Denu J.M. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005, 280:17187-17195.
216. Ng F., Tang B.L. Sirtuins' modulation of autophagy. J Cell Physiol 2013, 228:2262-2270.
217. Sundaresan N.R., Gupta M., Kim G., Rajamohan S.B., Isbatan A., Gupta M.P. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009, 119:2758-2771.
218. Ayissi V.B.O., Ebrahimi A., Schluesenner H. Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res 2014, 58:22-32.
219. Chung S., Yao H., Caito S., Hwang J., Arunachalam G., Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Polyphenols Health 2010, 501:79-90.
220. Caito S., Hwang J., Chung S., Yao H., Sundar I.K., Rahman I. PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. Biochem Biophys Res Commun 2010, 392:264-270.
221. Hwang J., Chung S., Sundar I.K., Yao H., Arunachalam G., McBurney M.W., et al. Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD. Arch Biochem Biophys 2010, 500:203-209.
222. Morselli E., Mariño G., Bennetzen M.V., Eisenberg T., Megalou E., Schroeder S., et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol 2011, 192:615-629.
223. Zhang Z., Lowry S.F., Guarente L., Haimovich B. Roles of SIRT1 in the acute and restorative phases following induction of inflammation. J Biol Chem 2010, 285:41391-41401.
224. Christian F., Anthony D.F., Vadrevu S., Riddell T., Day J.P., McLeod R., et al. p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways. Cell Signal 2010, 22:1576-1596.
225. Houslay M.D., Christian F. p62 (SQSTM1) forms part of a novel, reversible aggregate containing a specific conformer of the cAMP degrading phosphodiesterase, PDE4A4. Autophagy 2010, 6:1198-1200.
226. Mosieniak G., Adamowicz M., Alster O., Jaskowiak H., Szczepankiewicz A.A., Wilczynski G.M., et al. Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy. Mech Ageing Dev 2012, 133:444-455.
227. Lee Y.J., Kim N.-Y., Suh Y.-A., Lee C. Involvement of ROS in curcumin-induced autophagic cell death. Korean J Physiol Pharmacol 2011, 15:1-7.
228. Kim J.Y., Cho T.J., Woo B.H., Choi K.U., Lee C.H., Ryu M.H., et al. Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells. Arch Oral Biol 2012, 57:1018-1025.
229. Miki H., Uehara N., Kimura A., Sasaki T., Yuri T., Yoshizawa K., et al. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 2012, 40:1020-1028.
230. Puissant A., Auberger P. AMPK- and p62/SQSTM1-dependent autophagy mediate Resveratrol-induced cell death in chronic myelogenous leukemia. Autophagy 2010, 6:655-657.
231. Akar U., Ozpolat B., Mehta K., Fok J., Kondo Y., Lopez-Berestein G. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol Cancer Res 2007, 5:241-249.
232. Ozpolat B., Akar U., Mehta K., Lopez-Berestein G. PKCδ and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells. Autophagy 2007, 3:480-483.
233. Maioli E., Greci L., Soucek K., Hyzdalova M., Pecorelli A., Fortino V., et al. Rottlerin inhibits ROS formation and prevents NFκB activation in MCF-7 and HT-29 cells. BioMed Res Int 2010, 2009.
234. Cacicedo J.M., Yagihashi N., Keaney J.F., Ruderman N.B., Ido Y. AMPK inhibits fatty acid-induced increases in NF-κB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 2004, 324:1204-1209.
235. Domitrović R., Cvijanović O., Pernjak-Pugel E., Škoda M., Mikelić L., Crnčević-Orlić Ž. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem Toxicol 2013, 62:397-406.
236. Jia Y.-L., Li J., Qin Z.-H., Liang Z.-Q. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 2009, 11:918-928.
237. Teiten M.-H., Gaascht F., Cronauer M., Henry E., Dicato M., Diederich M. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol 2011, 38:603-611.
238. Mauthe M., Jacob A., Freiberger S., Hentschel K., Stierhof Y.-D., Codogno P., et al. Resveratrol-mediated autophagy requires WIPI-1-regulated LC3 lipidation in the absence of induced phagophore formation. Autophagy 2011, 7:1448-1461.
239. Proikas-Cezanne T., Codogno P. Beclin 1 or not Beclin 1. .. Autophagy 2011, 7:671-672.
240. Li S., Zhou Y., Fan J., Cao S., Cao T., Huang F., et al. Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats. Am J Pathol 2011, 179:2822-2834.
241. Mao H., Li Z., Zhou Y., Li Z., Zhuang S., An X., et al. HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2008, 295:F202-F214.
242. Blankson H., Holen I., Seglen P.O. Disruption of the cytokeratin cytoskeleton and inhibition of hepatocytic autophagy by okadaic acid. Exp Cell Res 1995, 218:522-530.
243. Gordon P.B., Holen I., Seglen P.O. Protection by naringin and some other flavonoids of hepatocytic autophagy and endocytosis against inhibition by okadaic acid. J Biol Chem 1995, 270:5830-5838.
244. Bowers J.L., Tyulmenkov V.V., Jernigan S.C., Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β 1. Endocrinology 2000, 141:3657-3667.
245. Ohshiro K., Rayala S.K., Kondo S., Gaur A., Vadlamudi R.K., El-Naggar A.K., et al. Identifying the estrogen receptor coactivator PELP1 in autophagosomes. Cancer Res 2007, 67:8164-8171.
246. Signorelli P., Munoz-Olaya J.M., Gagliostro V., Casas J., Ghidoni R., Fabriàs G. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett 2009, 282:238-243.
247. Chen T.-C., Hung Y.-C., Lin T.-Y., Chang H.-W., Chiang I., Chen Y.-Y., et al. Human papillomavirus infection and expression of ATPase family AAA domain containing 3A, a novel anti-autophagy factor, in uterine cervical cancer. Int J Mol Med 2011, 28:689-696.
248. Ruela-de-Sousa R., Fuhler G., Blom N., Ferreira C., Aoyama H., Peppelenbosch M. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis 2010, 1:e19. [12 pages].
249. Mojzis J., Varinska L., Mojzisova G., Kostova I., Mirossay L. Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res 2008, 57:259-265.
250. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer 1997, 80:1529-1537.
251. Bachmeier B.E., Nerlich A.G., Iancu C.M., Cilli M., Schleicher E., Vené R., et al. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 2007, 19:137-152.
252. Slivova V., Zaloga G., DeMichele S.J., Mukerji P., Huang Y.-S., Siddiqui R., et al. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutr Cancer 2005, 52:66-73.
253. Tanimura S., Kadomoto R., Tanaka T., Zhang Y.-J., Kouno I., Kohno M. Suppression of tumor cell invasiveness by hydrolyzable tannins (plant polyphenols) via the inhibition of matrix metalloproteinase-2/-9 activity. Biochem Biophys Res Commun 2005, 330:1306-1313.
254. Bhanot A., Sharma R., Noolvi M.N. Natural sources as potential anti-cancer agents: a review. Int J Phytomedicine 2011, 3:9-26.
255. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008, 75:787-809.
256. Kruszewski M., Bouzyk E., Oldak T., Samochocka K., Fuks L., Lewandowski W., et al. Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-l-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability. Teratog Carcinog Mutagen 2003, 1-11.
257. Samochocka K., Fokt I., Anulewicz-Ostrowska R., Przewloka T., Mazurek A., Fuks L., et al. Platinum (II) and palladium (II) complexes with methyl 3,4-diamino-2,3,4,6-tetradeoxy-α-l-lyxo-hexopyranoside. Dalton Trans 2003, 2177-2183.
258. Lewandowski W., Kalinowska M., Lewandowska H. The influence of metals on the electronic system of biologically important ligands. Spectroscopic study of benzoates, salicylates, nicotinates and isoorotates. Review. J Inorg Biochem 2005, 99:1407-1423.
259. Lewandowski W., Kalinowska M., Lewandowska H. The influence of halogens on the electronic system of biologically important ligands: spectroscopic study of halogenobenzoic acids, halogenobenzoates and 5-halogenouracils. Inorg Chim Acta 2005, 358:2155-2166.
260. Kalinowska M., Świsłocka R., Rzaczyńska Z., Sienkiewicz J., Lewandowski W. Spectroscopic (FT-IR, FT-Raman, UV, 1H, and 13C NMR) and theoretical studies of m-anisic acid and lithium, sodium, potassium, rubidium, and caesium m-anisates. J Phys Org Chem 2010, 23:37-47.
261. Kowczyk-Sadowy M., Świsłocka R., Lewandowska H., Piekut J., Lewandowski W. Spectroscopic (FT-IR, FT-Raman, 1H-and 13C-NMR), theoretical and microbiological study of trans o-coumaric acid and alkali metal o-coumarates. Molecules 2015, 20:3146-3169.